Stellar Reports Positive Research Results from KLH Glycosylation Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
Stellar Biotechnologies (SBOT) Gains 45% Following Positive Study Results
June 21, 2018 8:06 AM EDTStellar Biotechnologies (NASDAQ: SBOT) gains 45% in pre-open trade after the company announced the successful completion of a research study focused on the molecular composition of the company's KLH products. The quality analysis was completed as part of Stellar's initiatives to support later stage clinical trials of... More



